237 results on '"Moral, E"'
Search Results
2. Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis
3. Recomendaciones para la coordinación de los servicios de Neurología y Neurorradiología en la atención a pacientes con esclerosis múltiple
4. Gadolinium-enhanced brain lesions in multiple sclerosis relapse
5. Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
6. Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español
7. Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey
8. ¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave
9. A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis
10. Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra®) en pacientes con esclerosis múltiple
11. Evaluating factors influencing customers’ intention to eat Korean cuisine “Samgyeopsal” in the Philippines: A structural equation model forest classifier approach
12. P625 Randomized controlled trial on the effect of megaboluses of intravenous corticosteroids added to oral corticosteroids in the treatment of moderately active ulcerative colitis
13. Spanish consensus on the use of natalizumab (Tysabri®)-2013
14. Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013
15. Bifurcating Recursive Processing Elements in Neural Architectures for Applications in Multi-Dimensional Motor Control and Sensory Fusion in Noisy/Uncertain Environments
16. An Antimetabolite Toxin (Mangotoxin) is Produced by Pseudomonas syringae pv. syringae Isolated from Mango
17. Lesiones cerebrales captantes de gadolinio en el brote de los pacientes con esclerosis múltiple
18. Manejo de la inmunosupresión en pacientes trasplantados de riñón con COVID19. Estudio multicéntrico nacional derivado del registro COVID de la S.E.N
19. BEDSIDE-TO-BENCH EVALUATION OF PAIN: GRIP STRENGTH AS AN INDICATOR OF PAIN INDUCED BY INFLAMMATORY ARTHRITIS IN THE MOUSE: C031
20. The profile of evaluators of a medical publication in relation to the response
21. El perfil de los evaluadores de una publicación médica en relación a la respuesta
22. Recomendaciones para la coordinación de los servicios de Neurología y Neurorradiología en la atención a pacientes con esclerosis múltiple
23. Implementation of total body irradiation using VMAT
24. Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español
25. El dimetilfumarato: de un fármaco antipsoriático a un prometedor antineuropático
26. ¿Bacterias para la tolerancia analgésica a la morfina?
27. Will neurological care change over the next 5 years due to the COVID-19 pandemic?
28. ¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave : = Will neurological care change over the next 5 years due to the COVID-19 pandemic?
29. Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?
30. P746 Prevalence, features and outcomes of splachnic vein thrombosis in inflammatory bowel disease. A nationwide, retrospective study from the ENEIDA registry
31. Anticipation of age at onset in multiple sclerosis: methodologic pitfalls
32. Familial Creutzfeldt–Jakob disease with E200K mutation presenting with neurosensorial hypoacusis
33. Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients
34. Implementation of total body irradiation using VMAT.
35. A guide to treating gait impairment with prolonged-release fampridine (Fampyra (R)) in patients with multiple sclerosis
36. Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra®) en pacientes con esclerosis múltiple = A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis
37. P13.11 Metabolomics and molecular profiling in glioma patients: an interactomic approach
38. Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double‐blind, non‐inferiority trial
39. PND50 - SOCIAL RETURN ON INVESTMENT OF AN IDEAL APPROACH TO MULTIPLE SCLEROSIS WITHIN THE SPANISH NATIONAL HEALTH SYSTEM
40. Predictive biomarkers for optimal therapeutic response to fingolimod treatment in multiple sclerosis patients
41. Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra®) en pacientes con esclerosis múltiple
42. A guide to treating gait impairment with prolonged-release fampridine (Fampyra ® ) in patients with multiple sclerosis
43. Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra ® ) en pacientes con esclerosis múltiple
44. [PP.05.20] INFLUENCE OF A PROGRAM OF THERAPEUTIC EXERCISE IN DIFFERENT CLINICAL INDICATORS RELATED TO DYSLIPIDEMIA IN ADULT SUBJECTS FROM 26 TO 73 YEARS WITH A CARDIOVASCULAR RISK FACTOR
45. AB0714 Differentiating characteristics in patients with spondyloarthritis who have received differents anti-tnf therapies
46. FRI0186 Influence of immunogenicity to the first tnf-i therapy on response to the second biologic agent in ra patients
47. FRI0204 Comparison the long-term clinical outcomes between nontnf-inhibitors versus tnf-i in ra patients who failed to a first tnf-i
48. AB0198 Differential characteristics of patients discontinuating several biological therapies in a cohort of rheumatoid arthritis patients
49. SAT0168 Discontinuation of first biologic therapy in rheumatoid arthritis: main causes and correlation between secondary inefficacy and development of immunogenicity
50. Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double‐blind, non‐inferiority trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.